Category: Finance
-
Dana-Farber, Foundation Partner on Expanding Clinical Trials
Dana-Farber Cancer Institute in Boston and Leukemia & Lymphoma Society (LLS) in New York are collaborating on opening new sites for clinical trials to test blood cancer therapies. LLS is investing $1,050,000 over three years in the project. The Blood Cancer Research Partnership aims to make it easier for patients to take part in clinical…
-
U.K. University to Build Advanced Manufacturing Facility
University of Sheffield in the U.K. says it secured funding for an advanced manufacturing lab to study the needs of the aerospace industry and other high-value manufacturing industries. The £43 million ($US 66.3 million) lab, part of Sheffield’s Advanced Manufacturing Research Centre (AMRC), is supported by Boeing — which has its name on the official…
-
Bill Gates, VC Finance Science Collaboration Network
ResearchGate, an online network to encourage collaboration among scientists and sharing of research data, based in Berlin, closed a $35 million series C financing round, the third cycle of venture funding after start-up. The round was led by Microsoft founder Bill Gates and later-stage venture capital (VC) company Tenaya Capital. ResearchGate is a five-year old…
-
Stable, Inexpensive Nanoparticle Biosensors in Development
A materials scientist at Washington University in St. Louis is developing a new class of low-cost biosensors with metal nanoparticles that can be used in point-of-care medical testing, chemical detectors, and environmental monitors. Srikanth Singamaneni, a Washington University materials science professor, received last month a five-year, $400,000 Faculty Early Career Development Award from National Science…
-
NIH Funding Antibacterial Resistance Clinical Research Net
National Institute of Allergy and Infectious Diseases (NIAID), part of National Institutes of Health, is establishing a network of research universities to carry out clinical studies on antibacterial resistance. The first installment of $2 million will fund a leadership group of 20 researchers nationwide,with total potential funding of $62 million by 2019. The Antibacterial Resistance…
-
Indiana Companies, Universities Form Biosciences Institute
A consortium of life sciences companies and universities in Indiana launched today the Indiana Biosciences Research Institute, a public-private partnership that expects to be financed largely through corporate funds. The institute aims to attract top research talent and dollars to develop pharmaceuticals, diagnostics, medical devices, biologic therapies, and agricultural biotechnology, including animal health. Indiana Biosciences…
-
AstraZeneca Acquires Omega-3 Fatty Acid Drug Developer
The global pharmaceutical company AstraZeneca is buying the specialty pharmaceutical maker Omthera Pharmaceuticals in Princeton, New Jersey for $323 million, or $12.70 per share, an 88 percent premium over Omthera’s closing price of $6.75 per share on Friday. Omthera shareholders may also receive up to $4.70 per share in further milestone-achievement payments. Omega’s only product…
-
Airborne Wind Energy Systems Company Acquired by Google
Makani Power Inc., a company in Alameda, California developing airborne wind energy systems that fly in the air like kites, was acquired by Google, according to the company’s Web site. Financial terms of the acquisition were not disclosed. The company says its wind energy system operates like a wind turbine, but is flown from 250…
-
GSK Holds Challenge for Academic Drug Discovery Partners
The global pharmaceutical company GlaxoSmithKline (GSK) is holding a competition for academic partners to conduct drug discovery research, with the winners receiving an opportunity to develop the therapy with the company. The Discovery Fast Track program aims to speed up the drug discovery process and is open to academic researchers in the U.S. and Canada.…
-
Nimbus, Shire Partner on Rare Genetic Disease Drug Discovery
Nimbus Discovery, a biotechnology company in Cambridge, Massachusetts will discover and develop new small-molecule drug candidates to treat a set of rare genetic disorders, for the specialty pharmaceutical company Shire plc based in Ireland. Under the deal, Shire will provide Nimbus with periodic milestone payments, and while financial details of the agreement were not disclosed,…